clinical trials

Help wanted: Vaxxinity seeks a partner to press ahead with Alzheimer's treatment
Help wanted: Vaxxinity seeks a partner to press ahead with Alzheimer's treatment
Fierce Biotech
Vaxxinity
Alzheimer's disease
clinical trials
UB-311
Flag link:
Proposed FDA guidelines to strengthen oversight on accelerated approval cancer drugs
Proposed FDA guidelines to strengthen oversight on accelerated approval cancer drugs
Medical Marketing and Media
FDA
clinical trials
cancer
oncology
accelerated approvals
Flag link:
Novartis' Kisqali cuts recurrence risk in early-stage breast cancer
Novartis' Kisqali cuts recurrence risk in early-stage breast cancer
BioSpace
Novartis
clinical trials
Kisqali
breast cancer
Flag link:
Novo's high-dose Rybelsus win tees up regulatory filings—and new rivalries
Novo's high-dose Rybelsus win tees up regulatory filings—and new rivalries
Fierce Pharma
Novo Nordisk
Rybelsus
diabetes
clinical trials
Eli Lilly
Flag link:
AstraZeneca stays on course to challenge Alnylam with 66-week rare disease data
AstraZeneca stays on course to challenge Alnylam with 66-week rare disease data
Fierce Biotech
AstraZeneca
Ionis Pharmaceuticals
aplontersen
Alnylam
Onpattro
clinical trials
ATTRv-PN
Flag link:
FDA outlines plan for digital health technologies for clinical trials
FDA outlines plan for digital health technologies for clinical trials
RAPS.org
FDA
regulatory
clinical trials
digital health
Flag link:
Valneva, Pfizer delay end date of Lyme disease vaccine phase 3 trial to 2025
Valneva, Pfizer delay end date of Lyme disease vaccine phase 3 trial to 2025
Seeking Alpha
Pfizer
Valneva
clinical trials
vaccines
Lyme disease
VLA15
Flag link:
AbbVie clinches back-to-back clinical wins in ulcerative colitis, lupus
AbbVie clinches back-to-back clinical wins in ulcerative colitis, lupus
BioSpace
AbbVie
Skyrizi
ulcerative colitis
lupus
Rinvoq
clinical trials
Flag link:
Hard pressed for cash, Cyclerion looks for help funding rare disease drug
Hard pressed for cash, Cyclerion looks for help funding rare disease drug
Endpoints
Cyclerion
clinical trials
MELAS
zagociguat
Flag link:
Relmada, reeling from 2 late-phase flops, plots comeback for depression drug
Relmada, reeling from 2 late-phase flops, plots comeback for depression drug
Fierce Biotech
Relmada Therapeutics
clinical trials
depression
REL-1017
Flag link:
Sanofi and Regeneron's Dupixent scores trial win in tough-to-treat COPD
Sanofi and Regeneron's Dupixent scores trial win in tough-to-treat COPD
Fierce Pharma
Sanofi
Regeneron
Dupixent
COPD
clinical trials
Flag link:
Visus concludes subject enrolment in presbyopia therapy trial
Visus concludes subject enrolment in presbyopia therapy trial
Clinical Trials Arena
Visus Therapeutics
clinical trials
presbyopia
Brimochol
Flag link:
Astellas Announces Positive Findings from Phase 3 GLOW Trial of Zolbetuximab during March ASCO Plenary Series
Astellas Announces Positive Findings from Phase 3 GLOW Trial of Zolbetuximab during March ASCO Plenary Series
Drugs.com
Astellas
zolbetuximab
clinical trials
gastric cancer
Flag link:
AbbVie's Skyrizi aces ulcerative colitis study en route to new IBD showdown with J&J, Takeda
AbbVie's Skyrizi aces ulcerative colitis study en route to new IBD showdown with J&J, Takeda
Fierce Pharma
AbbVie
Skyrizi
IBD
ulcerative colitis
clinical trials
Flag link:
Novartis pulls the plug on UK-based cardiovascular study
Novartis pulls the plug on UK-based cardiovascular study
Endpoints
Novartis
clinical trials
Leqvio
UK
Cardiovascular
Flag link:
89bio’s PhII data add to quick succession of NASH readouts as field seeks turnaround
89bio’s PhII data add to quick succession of NASH readouts as field seeks turnaround
Endpoints
89Bio
NASH
clinical trials
gozafermin
Akero Therapeutics
Flag link:
New Yale study evaluates PAXLOVID's use in Long COVID recovery
New Yale study evaluates PAXLOVID's use in Long COVID recovery
Drugs.com
Pfizer
Paxlovid
COVI-19
Long COVID
clinical trials
Flag link:
Altimmune's obesity drug throws up safety concerns, shares plunge
Altimmune's obesity drug throws up safety concerns, shares plunge
Yahoo/Reuters
Altimmune
obesity
clinical trials
Flag link:
Neurofilament as a surrogate endpoint goes on trial in tofersen adcomm
Neurofilament as a surrogate endpoint goes on trial in tofersen adcomm
BioSpace
ALS
Biogen
Ionis Pharmaceuticals
FDA
tofersen
clinical trials
Flag link:
Incyte reports data from Phase IIb vitiligo therapy trial
Incyte reports data from Phase IIb vitiligo therapy trial
Clinical Trials Arena
Incyte
povorcitinib
vitiligo
clinical trials
Flag link:

Pages